Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.

The global nucleic acid isolation & purification market size was US$ 6,331.6 million in 2021. The global nucleic acid isolation and purification market size is forecast to reach US$ 12,241.2 million ...

Peptide nucleic acids (PNAs) represent a revolutionary class of synthetic nucleic acid analogues, in which the traditional sugar–phosphate backbone is replaced by a neutral N-(2-aminoethyl ...

Thalassemia advocacy group calls for standardized blood screening to prevent transfusion-transmitted infections, with legal ...

MAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second Generation Ateganosine Prodrugs for ...

Gene delivery is a key area in biomedicine, where nucleic acids are delivered into cells to treat diseases by modulating ...

Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...

The assay is heat stable at ambient or elevated temperatures, bypassing the need for cold chain during transport and storage.

All living organisms encode the amino acid sequences of proteins as nucleotide sequences (genetic information) in their ...

Molecular chaperones play a pivotal role in ensuring proper cellular protein homeostasis through their involvement in protein ...

The global ultrasensitive molecular amplification market is experiencing robust growth, driven by advances in diagnostic technologies and rising demand for precise detection of infectious and genetic ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.